Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Arcus Biosciences Inc. (RCUS)

11.76   0.19 (1.64%) 03-20 15:22
Open: 11.58 Pre. Close: 11.57
High: 12.18 Low: 11.25
Volume: 42,087 Market Cap: 524M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.103 - 12.172 12.172 - 12.235
Low: 11.266 - 11.339 11.339 - 11.405
Close: 11.464 - 11.582 11.582 - 11.688

Technical analysis

as of: 2019-03-20 2:57:52 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 14.83     One year: 17.33
Support: Support1: 11.27    Support2: 10.39
Resistance: Resistance1: 12.70    Resistance2: 14.83
Pivot: 11.82
Moving Average: MA(5): 11.66     MA(20): 11.80
MA(100): 10.96     MA(250): 12.88
MACD: MACD(12,26): 0.23     Signal(9): 0.30
Stochastic oscillator: %K(14,3): 53.43     %D(3): 50.77
RSI: RSI(14): 54.04
52-week: High: 17.60  Low: 8.57  Change(%): -33.1
Average Vol(K): 3-Month: 17632  10-Days: 13264

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
RCUS has closed below upper band by 47.9%. Bollinger Bands are 50% narrower than normal. The narrow width of the bands suggests low volatility as compared to RCUS's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 15 Mar 2019 18:11:07 Z
Infinity Inks Deal With Roche for Phase II Study of IPI-549

Fri, 04 Jan 2019 23:08:17 Z
Why Arcus Biosciences, Eldorado Gold, and Esperion Therapeutics Slumped Today

Tue, 06 Nov 2018 22:54:41 Z
Infinity (INFI) Q3 Earnings Beat Estimates, Revenues Up Y/Y

Thu, 09 Aug 2018 14:57:01 Z
Infinity (INFI) Posts Narrower-Than-Expected Loss in Q2

Fri, 13 Jul 2018 20:47:17 Z
Health Care Sector Update for 07/13/2018: PFE,RCUS,NVRO,ISRG,JNJ

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 44.53
Shares Float (M) 43.90
% Held by Insiders 1.40
% Held by Institutions 46.40
Shares Short (K) 1254
Shares Short P. Month (K)

Stock Financials

EPS -2.220
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS -1.849
Book Value (p.s.) 2.170
PEG Ratio
Profit Margin
Operating Margin -656.76
Return on Assets (ttm) -21.3
Return on Equity (ttm) -61.0
Qtrly Rev. Growth 25.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -43.00
Levered Free Cash Flow (M) -27.52

Stock Valuations

P/E -5.34
P/E Growth Ratio 0.02
P/BV 5.46
P/S 2198668800.00
P/CF -12.27

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.